Bullish Case: LDOS is +17.2% month-over-month and +3.1% over sixty days with real catalysts: DISA reaffirmed Leidos as sole source for combatant-command DoDNet migration on its $11B Defense Enclave contract, and X-Bow secured the LCCM rocket-booster deal with a ~3,000-missile initial Army order and 2027 full-rate production. Options flow is call-led (+33% volume, 95th percentile), bullish risk is 34% above bearish, and Helium's PDF modes at $140–145 sit right at spot with upside tail mass, favoring continuation toward $150–160.

Bearish Case: LDOS is still -24.6% year-over-year and -21.5% over two years; Helium's AI forecast is -3.6% with zero historical predictive correlation. The term structure is backwardated (Nov ATM ~38–53% IV vs Dec–May ~32–40%), meaning near-term event risk is priced higher and IV decay, not appreciation, may be the trade. Market IV (45.8% Nov) exceeds Helium's curve, and the market PDF is left-shifted with heavy mass at $135–145, capping upside while SPY downside-vol skew amplifies any risk-off drawdown.

Potential Outcomes:

1. ~35%: Range $138–148 through Dec 19 expiry; IV compresses as Nov skew decays — falsifiable: Nov 21 close within band.
2. ~25%: Breakout $148–158 on LCCM order conversion or DISA Enclave expansion — falsifiable: >$150 close before Dec earnings.
3. ~30%: Pullback $125–138 on SPY risk-off or federal budget/guidance noise — falsifiable: <$138 close within 15 sessions.
4. ~10%: Tail <$120 or >$165 on macro shock or major award.

October 31, 2026